Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Barboval oral drops 2p x 25 ml — Made in Ukraine — Free Delivery
Barboval oral drops 2p x 25 ml — Made in Ukraine — Free Delivery
Brand:
Farmak
Product Code:
Barboval
Availability:
In Stock
$19.79
Add to Cart
Description
Indication
Neuroses accompanied by increased excitability, insomnia, hysteria; as part of the complex treatment of mild attacks of angina pectoris, angina pectoris of the initial stage, tachycardia of functional genesis, with spasms of the stomach and intestines, flatulence.
Application
Barboval should be taken internally with a small amount of liquid or on a piece of sugar under the tongue.
Doses and duration of treatment are set by the doctor individually. Adults usually take 10-15 drops 2-3 times a day for 10-15 days.
It is better to take the preparation 20-30 minutes before meals.
After a break of 10-15 days, the course of treatment can be repeated.
Contraindication
Hypersensitivity to any components of the preparation, liver and kidney failure, hepatic porphyria, severe heart failure, severe arterial hypotension, acute myocardial infarction, diabetes, depression, myasthenia gravis, alcoholism, preparation and medication addiction, respiratory diseases with shortness of breath, obstructive syndrome .
Side effects
Usually the preparation is well tolerated. the development of the following adverse reactions is possible:
from the side of the digestive system: constipation, a feeling of heaviness in the epigastric region, with long-term use - impaired liver function, nausea, vomiting;
from the nervous system: weakness, ataxia, impaired coordination of movements, nystagmus, hallucinations, paradoxical excitement, decreased concentration of attention, fatigue, slowing of reactions, headache, cognitive impairment, confusion, drowsiness, light dizziness;
from the hematopoietic organs: anemia, thrombocytopenia, agranulocytosis;
from the side of the cardiovascular system: arterial hypotension, bradycardia; from the immune system: hypersensitivity reactions, including angioedema, allergic reactions, including skin rashes, itching, urticaria;
from the skin and mucous membranes: Stevens-Johnson syndrome, toxic epidermal necrolysis;
on the part of the musculoskeletal system: with long-term use of preparations containing phenobarbital, there is a risk of osteogenesis disorder;
other: difficulty breathing.
Long-term use of bromine-containing preparations can lead to bromine poisoning, which is characterized by the following symptoms: CNS depression, depressed mood, confusion, ataxia, apathy, conjunctivitis, rhinitis, lacrimation, acne or purpura.
Special instructions
The presence of phenobarbital in the medicinal product can lead to the risk of developing Stevens-Johnson and Lyell syndrome, which is most likely in the first weeks of treatment. long-term use is not recommended due to the risk of preparation addiction, possible accumulation of bromine in the body and the development of bromine poisoning. in cases where the pain in the heart area does not go away after taking the preparation, it is necessary to consult a doctor to rule out acute coronary syndrome. the preparation should be prescribed with caution in arterial hypotension, hyperkinesis, hyperthyroidism, hypofunction of the adrenal glands, acute and constant pain, acute preparation intoxication.
Use during pregnancy or breastfeeding. The preparation should not be used by women during pregnancy or breastfeeding.
The ability to influence the speed of reaction when driving a motor vehicle or working with other mechanisms. The preparation can cause drowsiness and dizziness, therefore, during treatment, patients are not recommended to work with dangerous mechanisms and drive vehicles.
Children. There is no experience of using the preparation to treat children, so they are used in pediatric practice.
Interactions
Simultaneous use with neuroleptics and tranquilizers potentiates, and with stimulants of the central nervous system - weakens the effect of each component of the preparation. barboval, containing derivatives of barbituric acid, enhances the effect of local anesthetics, analgesics and hypnotics. alcohol enhances the effects of the preparation and can increase its toxicity. the effect of the preparation increases against the background of the use of valproic acid preparations. the presence of phenobarbital in the composition of Barboval can induce liver enzymes, and this makes its simultaneous use with preparations that are metabolized in the liver (with coumarin derivatives, griseofulvin, glucocorticoids, oral contraceptives, cardiac glycosides, antimicrobial, antiviral, antifungal, antiepileptic, anticonvulsant , psychotropic, oral hypoglycemic, hormonal, immunosuppressive, cytostatic, antiarrhythmic, antihypertensive preparations, etc.), as their effectiveness will decrease as a result of a higher level of metabolism. MAO inhibitors prolong the effect of phenobarbital. rifampicin can reduce the effect of phenobarbital.
With the simultaneous use of phenobarbital with gold preparations, the risk of kidney damage increases.
With long-term use of phenobarbital with NSAIDs, there is a risk of stomach ulcers and bleeding.
Simultaneous use of phenobarbital with zidovudine increases the toxicity of both preparations
The preparation increases the toxicity of methotrexate. Alcohol should be avoided while taking the preparation.
Overdose
With long-term or frequent use, preparation accumulation may occur, which leads to clinical manifestations of overdose, namely:
depression of the central nervous system, which is eliminated by the use of central nervous system stimulants (caffeine, cordiamine, etc.);
nystagmus, ataxia, decrease in blood pressure, deviations in the blood formula.
Manifestations of chronic bromine poisoning are depression, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, impaired movement coordination. Symptomatic therapy is prescribed to eliminate these manifestations.
Continuous long-term use of the preparation can cause addiction, preparation dependence, withdrawal syndrome, and sudden cessation of use - withdrawal syndrome. Long-term use of the preparation is sometimes accompanied by increased psychodynamic activity instead of the expected sedation.
Symptoms of overdose: suppression of breathing, until it stops; depression of the central nervous system, up to coma; suppression of cardiovascular activity, including rhythm disturbances, lowering of blood pressure, up to a collaptoid state; nausea, weakness, decrease in body temperature, decrease in diuresis.
Treatment is symptomatic.
Storage conditions
In the original packaging at a temperature not higher than 25 °C.
0 reviews
There are no reviews for this product.